| __timestamp | Amneal Pharmaceuticals, Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 79838000 |
| Thursday, January 1, 2015 | 136870000 | 121816000 |
| Friday, January 1, 2016 | 204747000 | 117633000 |
| Sunday, January 1, 2017 | 191938000 | 117456000 |
| Monday, January 1, 2018 | 210451000 | 171984000 |
| Tuesday, January 1, 2019 | 202287000 | 257452000 |
| Wednesday, January 1, 2020 | 190585000 | 477643000 |
| Friday, January 1, 2021 | 209563000 | 540684000 |
| Saturday, January 1, 2022 | 200046000 | 651496000 |
| Sunday, January 1, 2023 | 167778000 | 666563000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc. have shown contrasting trends in their R&D investments. From 2014 to 2023, Amneal's R&D expenses have remained relatively stable, peaking in 2018 with a 97% increase from 2014, before slightly declining in recent years. In contrast, PTC Therapeutics has demonstrated a robust upward trajectory, with a staggering 735% increase in R&D spending over the same period. By 2023, PTC's R&D expenses were nearly four times that of Amneal's, highlighting its aggressive pursuit of innovation. This divergence underscores the strategic differences between the two companies, with PTC Therapeutics clearly prioritizing R&D as a driver for future growth.
R&D Insights: How AbbVie Inc. and PTC Therapeutics, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc.
R&D Insights: How argenx SE and Amneal Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How Alnylam Pharmaceuticals, Inc. and PTC Therapeutics, Inc. Allocate Funds
R&D Spending Showdown: Biogen Inc. vs Amneal Pharmaceuticals, Inc.
Analyzing R&D Budgets: United Therapeutics Corporation vs Amneal Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Corcept Therapeutics Incorporated vs Amneal Pharmaceuticals, Inc.
Comparing Innovation Spending: TG Therapeutics, Inc. and PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc.
Analyzing R&D Budgets: Amneal Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.
PTC Therapeutics, Inc. vs MorphoSys AG: Strategic Focus on R&D Spending
R&D Insights: How PTC Therapeutics, Inc. and Novavax, Inc. Allocate Funds